Product information and disease descriptionProduct descriptionProduct information
Effect of VK2735 on quality measures
3 evidence topics · 3 sources
Product-specific effect on quality measures
No evidence found.
Merit-based Incentive Payment System 2026 measure 128: body mass index screening and follow-up plan
Healthy People 2030 objective NWS-03: proportion of adults with obesity
| Field | Objective record |
|---|---|
| Objective | “Reduce the proportion of adults with obesity” |
| National baseline | “38.6” |
| National baseline definition | “percent of adults aged 20 years and over had obesity in 2013-16” |
| Most recent data | “40.2” |
| Most recent data period | “(2021-23)” |
| National target | “36.0” |
| National status | “Little or no detectable change” |
| Desired direction | “Decrease desired” |
| Data source | “National Health and Nutrition Examination Survey (NHANES), CDC/NCHS” |
Obesity quality measures in federal reporting and payment programs
“Obesity quality measures have entered various stages of testing and development, but only a select few are included in reporting and payment programs.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“One process measure for adults, "Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan" is used in Medicare.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“No outcome or digital quality measure exists for the disease of obesity.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The general absence of quality measures for obesity means that there are no objective measures to address the quality of obesity care or its outcome.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote